Power3 Medical Products, Inc. (PWRME)
Breast cancer can have a number of symptoms but usually shows as a lump or thickening in the breast tissue (although most breast lumps are not cancerous). If cancer is detected at an early stage, it can be treated before it spreads to nearby parts of the body. There are several different types of breast cancer, which can develop in different parts of the breast. Breast cancer is often divided into non-invasive and invasive types.

Non-invasive breast cancer: Non-invasive breast cancer is also known as cancer or carcinoma in situ or pre-cancerous cells. This cancer is found in the ducts of the breast and has not developed the ability to spread outside the breast.

Invasive breast cancer: Invasive cancer has the ability to spread outside the breast, although this does not mean it necessarily has spread. The most common form of breast cancer is invasive ductal breast cancer, which develops in the cells that line the breast ducts.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

Power3 Medical Products, Inc. is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:
Breast Cancer, Chemotherapeutic Drug Resistance, Alzheimer’s disease, Leukemia, ALS (Lou Gehrig’s Disease), Gastrointestinal Disease, Parkinson’s Disease and Metabolic Syndrome.

Power3 Medical Products, Inc. (PWRME) announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3’s diagnostic test, and focused on Power3’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

For more information about Power3 Medical Products, Inc. visit website http://www.power3medical.com

***************************************

Adept Technology, Inc. (Nasdaq:ADEP) a leading provider of intelligent vision-guided and autonomous mobile robotic solutions, today announced financial results for its fiscal 2011 third quarter ended March 26, 2011.Revenues for the third quarter of fiscal 2011 were $12.8 million, which compares to $14.3 million for the third quarter of fiscal 2010 and $13.3 million for the previous quarter of fiscal 2011. The decline in revenues is due to the downturn in the historically cyclical disk drive industry which helped drive growth during fiscal 2010. Revenues from Adept’s core markets, including packaging, automotive, industrial, electronics and solar, as well as sales from MobileRobots partially offset the decline, and taken together, more accurately reflect the Company’s ongoing performance in its core markets. Adept reported a GAAP net loss of $3.3 million, or $0.37 per share in the third quarter of fiscal 2011, which compares to net income of $596,000, or $0.07 per diluted share in the third quarter of fiscal 2010, and a net loss of $1.7 million, or $0.20 per share in the previous quarter.

Adept Technology, Inc., together with its subsidiaries, provides intelligent robotics systems and services for packaging, solar, medical, disk drive/electronics, machine tool automation, and automotive electronics sectors. Its product range includes application software, integrated real-time vision and multi-axis motion controls, machine vision systems and software, industrial robots, and vision-based flexible parts feeders.

****************************************

Synthesis Energy Systems, Inc. (Nasdaq:SYMX) a global energy and gasification technology company that provides products and solutions to the energy and chemicals industries, announced today that it will release financial results for the third quarter of fiscal 2011, ended March 31, 2011, on Tuesday, May 10, 2011, before the market open. Senior management will hold a conference call to review the Company’s financial results for this period and provide an update on corporate developments at 8:30 a.m. Eastern Time. To access the live webcast, please log on to the Company’s website at www.synthesisenergy.com. Alternatively, domestic callers may participate in the live conference call by dialing (800) 860-2442 and international callers should dial (412) 858-4600. An archived version of the webcast will be available on the SES Web site through June 13, 2011. A telephone replay of the conference call will be available approximately one hour after the completion of the call through June 13, 2011. Domestic callers can access the replay by dialing (877) 344-7529. International callers should dial (412) 317-0088. The PIN access number for the live call and the replay is 450545#.

SES provides technology, equipment and engineering services for the conversion of low rank, low cost coal and biomass feedstocks into energy and chemical products. Its strategy is to create value through providing technology and equipment in regions where low rank coals and biomass feedstocks can be profitably converted into high value products through its proprietary U-GAS® fluidized bed gasification technology, which SES licenses from the Gas Technology Institute. U-GAS® gasifies coal cost effectively, without many of the harmful emissions normally associated with coal combustion plants.

*****************************************

Spire Corporation (Nasdaq:SPIR) a global solar company providing capital equipment and turn-key manufacturing lines to produce photovoltaic (PV) modules, announced that it kicked-off its efforts to give back to both the community and the environment last Friday, Earth Day, by planting a golden forsythia on the Minuteman Bikeway, a branch of the Rails-to-Trails Conservancy. The plant symbolizes Spire’s monthly commitment to cleaning up the litter and excess debris from the trail.

Spire Corporation is a global solar company providing capital equipment and turn-key production lines to manufacture PV modules. To learn more about Spire Corporation, visit www.SpireCorp.com or email PR@SpireCorp.com.

Sign up for free stock alerts at http://www.pennygovernance.com/signup

***************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyGovernance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyGovernance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(read more @ http://pennygovernance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRME.OB).